Nevoiyt A. Clinico-patogenetic foundation of Glutargin usage at the alcoholic liver disease

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0404U003390

Applicant for

Specialization

  • 14.01.02 - Внутрішні хвороби

27-08-2004

Specialized Academic Board

Д 52.600.01

Essay

The dissertation focuses on the problems of the patients' treating effectiveness increase by using Glutargin and its combinations with traditional hepatoprotectors, the patients suffering from an alcoholic liver disease. It has been found that Glutargin being used at treating patients with an alcoholic liver disease shows a vivid detoxic and protein syhesiging effects, influences positively upon the collagen exchange, increases hepatocytes' resistance, and assists the clinico-biochemical remission of the disease. The results of using Glutargin and its combinations with traditional hepatoprotectors on the basis of the essential phospholipids and silymarin have been estimated in 157 patients with alcoholic liver disease at stage of chronic hepatitis in the comparative aspect. The data received prove the expediency of Glutargin usage in the complex therapy of the alcoholic liver disease.

Files

Similar theses